|
End-of-day quote
Egyptian Exchange
13/09/2026
|
5-day change | 1st Jan Change | ||
| 1.680 EGP | 0.00% |
|
-0.59% | +47.37% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Chart: Technical Analysis
Egyptian ExchangeEGP
| Markets | Quality | ||
|---|---|---|---|
Egyptian Exchange
| MCRO | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bearish |
| Resistance | 1.71 | 1.71 | 1.96 |
| Spread/Res. | -1.75% | -1.75% | -14.29% |
| Spread/Supp. | +5.66% | +26.32% | +61.23% |
| Support | 1.59 | 1.33 | 1.042 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MCRO Stock
- Charts Macro Group Pharmaceuticals (Macro Capital) S.A.E
Select your edition
All financial news and data tailored to specific country editions
